Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make A Difference
By Brandon Newman, CEO & Founder of Xevant
In the ever-evolving healthcare landscape, transparency in pharmacy benefit management (PBM) has emerged as a critical issue. The discussion surrounding driving down prescription drug costs and increasing access to affordable medications has brought attention to the practices of PBMs. However, achieving true transparency requires more than just buzzwords; it necessitates access to real-time data that empowers consumers to make informed decisions about their healthcare. In this piece, we will explore the importance of real-time transparency in PBMs and highlight how Xevant, a leading platform, is revolutionizing the industry.
Leadership Excellence in Healthcare Technology: Unveiling Brandon Newman’s Visionary Path, Collaborative Culture, and Disruptive Strategies For Success At Xevant
Join us as we explore Brandon Newman’s inspiring journey, uncover his unique perspectives on leadership and employee satisfaction, and gain valuable insights into the future of healthcare innovation.
This exclusive interview promises to shed light on the remarkable vision and achievements of a true industry trailblazer.
4 PBM Trends To Watch — and, Yes, Transparency Is One of Them
Specialty drugs as a growing share of the pharmacy spend and the push for transparency are all-too familiar themes in the pharmacy benefit management (PBM) industry, but they have staying power as the top trends to watch, said the opening speaker of the 2022 Annual National Conference of the Pharmacy Benefit Management Institute in Orlando.
Xevant Revolutionizes Pharmacy Benefits Using Data Analysis
Xevant is laser-focused on reducing the cost and inefficiencies of healthcare by delivering analytics through automation. A key driver for increased healthcare cost is the onslaught of specialty/biologic medications that is quickly expanding the focus to include pharmacy benefits management in the pursuit of containing costs.
Xevant: Enabling Affordable Healthcare Through Automated Data Analytics
As we eliminate the extensive time and resources required to manage healthcare costs, we will begin to whittle away at the $1 trillion in current wasteful spending. We will start to see signs of improvement in a primarily broken US healthcare system. Reduction in cost yields greater healthcare affordability, accessibility, and availability.
Xevant – Reducing Healthcare Costs Through Automated Analytics
Healthcare is a $4 trillion business with 25% considered wasteful. Historical approaches to eliminate waste within healthcare have required a massive amount of time and resources aggregating data and running and analyzing reports, only to recover 1-3% of losses.
Xevant: Advanced and Automated Analytics For Healthcare Data
Being a huge industry with over $4 trillion business around 25% of it is considered wasteful. This is basically because of the huge workload, repetitive and error-prone processes. At this challenging point, helping businesses in the healthcare space simplify cost and streamlining operations is Xevant.
Xevant’s RebateLogic
Even in the wake of the pandemic, increases in prescription drug prices continue to “outpace inflation,” according to a recent AARP survey. Seventy-nine percent of U.S. adults claim that the “cost of prescription drugs is unreasonable,” and almost three in ten adults reported that because of high cost, they didn’t take their medicines as prescribed at some point in the last year.
Brandon Newman: Unleashing the True Potential of Technology in Healthcare
In the modern digital era of business, technological advancements and innovation continue to impact all industries. In healthcare, these developments play a vital role for customers and enterprises alike. Devices like smartphones and tablets have replaced orthodox monitoring and recording systems due to their higher efficiency, precision, and faster troubleshooting ability.
Economic Outlook Summit: B2B – the Future of Collaboration and How It Shapes Our Economy
This November, Utah Business hosted an exclusive summit for business with dozens of panels hosted by some of our favorite experts. This panel, moderated by Nathan Paddock, director of Business Development at Wells Fargo will take a deeper look at how different businesses have worked in partnership to create solutions to some of businesses’ biggest challenges. With panelists Katelin Roberts, executive director at BioHive; Brandon Newman, CEO & co-founder at Xevant; Ryan Jones, EVP & chief lending officer at Altabank; Amy Osmond Cook, CMO, at Simplus; Scott Johnson, Founder & CEO at Motivosity.
